- Home
- CRNX vs SYNA Comparison
CRNX vs SYNA Comparison
Compare CRNX & SYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- SYNA
- Stock Information
- Founded
- CRNX 2008
- SYNA 1986
- Country
- CRNX United States
- SYNA United States
- Employees
- CRNX N/A
- SYNA N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- SYNA Computer peripheral equipment
- Sector
- CRNX Health Care
- SYNA Technology
- Exchange
- CRNX Nasdaq
- SYNA Nasdaq
- Market Cap
- CRNX 2.8B
- SYNA 2.7B
- IPO Year
- CRNX 2018
- SYNA 2002
- Fundamental
- Price
- CRNX $41.56
- SYNA $69.50
- Analyst Decision
- CRNX Buy
- SYNA Strong Buy
- Analyst Count
- CRNX 12
- SYNA 6
- Target Price
- CRNX $74.45
- SYNA $90.50
- AVG Volume (30 Days)
- CRNX 2.1M
- SYNA 348.8K
- Earning Date
- CRNX 11-06-2025
- SYNA 11-06-2025
- Dividend Yield
- CRNX N/A
- SYNA N/A
- EPS Growth
- CRNX N/A
- SYNA N/A
- EPS
- CRNX N/A
- SYNA N/A
- Revenue
- CRNX $1,392,000.00
- SYNA $1,074,300,000.00
- Revenue This Year
- CRNX $428.87
- SYNA $11.05
- Revenue Next Year
- CRNX $958.11
- SYNA $9.89
- P/E Ratio
- CRNX N/A
- SYNA N/A
- Revenue Growth
- CRNX 0.51
- SYNA 11.98
- 52 Week Low
- CRNX $24.10
- SYNA $41.80
- 52 Week High
- CRNX $62.53
- SYNA $89.81
- Technical
- Relative Strength Index (RSI)
- CRNX 54.07
- SYNA 53.76
- Support Level
- CRNX $43.72
- SYNA $63.84
- Resistance Level
- CRNX $45.95
- SYNA $70.71
- Average True Range (ATR)
- CRNX 1.78
- SYNA 2.57
- MACD
- CRNX -0.37
- SYNA 0.21
- Stochastic Oscillator
- CRNX 19.30
- SYNA 91.54
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About SYNA Synaptics Incorporated $0.001 Par Value
Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.